ACE and ARB Agents in the Prophylactic Therapy of Migraine—How Effective Are They?
- 554 Downloads
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are antihypertensive agents that can be considered for migraine preventative therapy. Although the exact mechanisms by which ACE inhibitors and ARBs may work for migraine prophylaxis are unknown, there are several plausible hypotheses as to why modulating the activity of the renin angiotensin system could result in migraine prevention. Clinical trials of ACE inhibitors and ARBs provide evidence that they are effective and generally well tolerated when used for migraine prophylaxis. Based upon biologic plausibility, the quality of evidence for efficacy from clinical trials, and recommendations in published guidelines, we consider ACE inhibitors and ARBs as second- or third-line options for migraine prophylaxis.
KeywordsMigraine Headache Angiotensin converting enzyme inhibitors Angiotensin receptor blockers
Compliance with Ethical Standards
Conflict of Interest
Rashmi B. Halker M.D., Amaal J. Starling M.D., and Bert B. Vargas declare that they have no conflict of interest.
Todd J. Schwedt has received personal fees from Supernus, Allergan, and Zogenix.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
References and Recommended Reading
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 6.•Sonbolestan SA et al. Efficacy of enalapril in migraine prophylaxis: a randomized, double-blind, placebo-controlled trial. Int J Prev Med. 2013;4(1):72–7. This is a recent randomized placebo-controlled trial of an ACE inhibitor for the preventative treatment of migraine.PubMedPubMedCentralGoogle Scholar
- 8.Shamliyan TA, Kane RL, and Taylor FR. In Migraine in adults: preventive pharmacologic treatments 2013: Rockville (MD).Google Scholar
- 9.••Silberstein SD et al. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the quality standards subcommittee of the American academy of neurology and the American headache society. Neurology. 2012;78(17):1337–45. These are evidence-based guidelines on the preventative treatment of migraine from the American Academy of Neurology and the American Headache Society.CrossRefPubMedPubMedCentralGoogle Scholar
- 13.•Stovner LJ et al. A comparative study of candesartan versus propranolol for migraine prophylaxis: a randomised, triple-blind, placebo-controlled, double cross-over study. Cephalalgia. 2013;34(7):523–32. This is a recent randomized controlled trial of an ARB for the preventative treatment of migraine.CrossRefPubMedGoogle Scholar